The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | Content | |
|---|---|---|---|
| 21/10/2021 | Liquidity contracts and specialits | The Company informs that it has made a deposit in the Liquidity Contract account. | |
| 21/10/2021 | On business and financial situation | ROVI informs of the delay in the decision on Risperidone ISM® by the FDA | |
| 4/10/2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the third quarter of 2021 | |
| 1/09/2021 | On business and financial situation | ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine | |
| 29/08/2021 | On business and financial situation | ROVI informs on the evolution of the investigation of particulate matter having been seen in certain drug product vials of the Moderna COVID-19 vaccine distributed in Japan | |
| 26/08/2021 | On business and financial situation | ROVI informs on the notification of particulate matter having been seen in certain drug product vials of the Moderna's COVID-19 vaccine distributed in Japan | |
| 28/07/2021 | On business and financial situation | ROVI releases the first half 2021 results presentation | |
| 28/07/2021 | On business and financial situation | The company releases the press release related to first half 2021 financial results | |
| 16/07/2021 | On Corporate Governance | ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company | |
| 13/07/2021 | Laboratorios Farmacéuticos Rovi regrets the passing of its President Juan López-Belmonte | The Company informs about the passing of its President Juan López-Belmonte López |